NVDA
NVIDIA
-- 117.520 TSLA
Tesla
-- 235.860 INTC
Intel
-- 24.120 PLTR
Palantir
-- 86.100 AAPL
Apple
-- 215.240 
🟠Watchlist, FEBRUARY 7,2025, Friday. NFA- DrJag8 (I am not sure if I’ll be trading tomorrow)
NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If you don’t appreciate my watchlist, STAY AWAY and I won’t think twice blocking you. I shun uncouth and toxic people in my life.
AGAIN, NEVER OPEN A POSITION WITHOUT ANALYZING CHART, INDICATORS, ORDER BOOK, SHORTS AVAILABILITY
To my silent stalkers: You are welcome 🤣
▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️
NEWS FEBRUARY 6 (Thursday)
$Aurora Cannabis (ACB.US)$ $SNDL Inc (SNDL.US)$ PR after market closed 2/6 Announces Supply Agreement. SNDL is expected to supply Aurora with premium cannabis flower product. The term of the agreement is for three years with an option to extend and an estimated value of $27 million.
$Alumis (ALMS.US)$ $Acelyrin (SLRN.US)$ SPR 2/6 Alumis and ACELYRIN to Merge Creating a Late-Stage Clinical Biopharma Company Dedicated to Innovating, Developing and Commercializing Transformative Therapies for Immune-mediated Diseases. Pro forma cash position of approximately $737 million as of December 31, 2024, provides runway into 2027. Alumis and ACELYRIN stockholders to own ~55% and ~45%, respectively. This involves dilution as new shares Will be issued to facilitate merger. This may go up if market sentiment perceives the merger outweighs dilution.
$Clear Channel Outdoor (CCO.US)$ PR 2/5 Sells Businesses in Mexico, Peru and Chile to Global Media US LLC! Receives $20 Million Cash at Closing Based on $34 Million Enterprise Value. No dilution risk
$Coya Therapeutics (COYA.US)$ PR 2/6 Reports Statistically Significant Improvement of Inflammatory Blood Markers in Patients with Alzheimer's Disease Following Monthly Dosing with Low-Dose IL-2, Further Supporting Clinical Development. Low float. COH $37.3M good for 42.5 months
$Dare Bioscience (DARE.US)$ PR 2/6 Announces Funding Award Notice from the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Support DARE-HPV Development Up to $2 million in grant funding. Low float. COH $60K. High risk for dilution
$Farmer Bros (FARM.US)$ PR AH 2/6 ER Second quarter fiscal 2025 net sales of $90 millio, Gross margin increased 43.1% YoY. Net income of $210,000 and improved adjusted EBITDA1 of $5.9 million. COH $2.5M
$Fusion Fuel Green (HTOO.US)$ PR AH 2/6 Complied with listing requirements. Low float.
$Jeffs' Brands (JFBR.US)$ PR 2/6 Enters Into Definitive Agreement to Complete Fort Products’ Merger with a Publicly Traded Company, at a Valuation of up to approximately $12 Million. The merger values Fort Products at approximately US $11.9 million, with Impact's valuation at US $3.3 million. Low float. SI 21.87%. COH $1M good for 1.8 months
$Mangoceuticals (MGRX.US)$ PR 2/5 Advances H1N1 Efficacy Study Noting Significant Reduction in Viral Load in Phase 1 Studies and Engages Vipragen Biosciences to Structure H5N1 Cohort for Expanded Research. Low float. No cash on hand
$Maris-Tech (MTEK.US)$ PR 2/6 secured its first Eastern European defense order through its UK-based distributor for multiple Jupiter Nano systems. The units will be integrated into weapon systems for a defense project in Eastern Europe, marking the company's expansion into a new defense market. 2/5 13G/A filed 8.1% up from 6.23%.
$New Century Logistics (NCEW.US)$ PR 2/6 2 13Gs 39% and 16%. This ran but it was news AH so it may get attention tomorrow too. Low float. 0 shares LTB. COH $360K
$Algorhythm (RIME.US)$ PR 2/5 Company Clears All Outstanding Cashless Warrants from December Capital Raise. ALSO, this is going on RS Feb 10 so may have probable pre RS spike
$Satellogic (SATL.US)$ S PR 2/6 Satellogic and Telespazio Brasil Announce Multi-Year Contract for Low-Latency Satellite Imagery for the Brazilian Air Force. COH $6.5M good for 1.5 months
$SuperCom (SPCB.US)$ PR 2/6 SuperCom Secures over 200% growth in PureTrack GPS Monitoring units in Large Nationwide European EM Project and is expected to surpass 400% growth by end of 2025. Low float. Remember this has a 13G filed 1/31. SI 12.63%. COH $1M
$Trinity Biotech (TRIB.US)$ PR 2/6 The latest analysis shows Trinity Biotech’s redesigned CGM sensor improves first-day accuracy, with a ~35% better Mean Absolute Relative Difference (MARD) and over 50% better Mean Absolute Difference (MAD) than the previous Waveform product. First-day accuracy has been a challenge industry-wide due to the body’s response to sensor insertion. Relatively low float. COH $10.9M good for 29.8 months
$Urban-gro (UGRO.US)$ PR 2/6 secured a significant $24 million construction contract with a leading Midwest-based Multi-State Operator (MSO) for building a state-of-the-art vertically integrated cannabis facility.
▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️
PREVIOUS DAYS’ NEWS FOR POSSIBLE DELAYED MARKET REACTION (I advise you to save these news because I won’t repost the details and will just be ticker symbols.
$Cognition Therapeutics (CGTX.US)$ PR 1/30 Positive Phase 2 Study of Zervimesine in Dementia with Lewy Bodies (DLB).
$Datasea (DTSS.US)$ PR 2/5 Pre-Announces Second Quarter Revenue of $20.5 Million, up 81% Year-over-Year; Gross profit increase of 310% YoY. China low float stock.
$EyePoint Pharmaceuticals (EYPT.US)$ PR 2/5 Announces Positive Six-Month Results for the Phase 2 VERONA Clinical Trial of DURAVYU™ for Diabetic Macular Edema Meeting Primary and Secondary Endpoints. Beaten by shorts today. SI 21.78%. COH $348M.
$Helix Energy Solutions (HLX.US)$ PR AH 2/5 Awarded Significant Trenching Services Contract, one of the largest trenching awards of the company. Helix is a global leader in subsea robotics and trenching. No dilution risk
$Inspira Technologies Oxy (IINN.US)$ PR 2/5 announced the integration of a next-generation oxygenation indicator into its AI-powered HYLA blood sensor technology. This enhancement enables continuous monitoring of tissue oxygenation and early hypoxia detection without requiring intermittent blood draws. Low float. SI 16.54%. COH $4.5M good for 5.6 months
$Knightscope (KSCP.US)$ Achieves Full Federal Risk and Authorization Management Program (FedRAMP®) Authorization, Unlocking Federal Growth.
$Comstock Inc (LODE.US)$ PR 2/4 Approved for $152 Million Allocation for Oklahoma Qualified
$Lucky Strike Entertainment (LUCK.US)$ PR 2/5 ER Net income improved significantly to $28.3M from prior year loss of $63.5M. Maintained positive guidance for FY2025 with expected revenue of $1.23-1.28B. Low float. SI 56.61%. 0 shares LTB.
$MAIA Biotechnology (MAIA.US)$ PR 2/4 Announces Positive Efficacy Updates for Phase 2 THIO-101 Trial in Advanced Non-Small Cell Lung Cancer. Showed median overall survival of 16.9 months compared to 56 months in similar setting.
$Nexalin Technology (NXL.US)$ PR 2/3 Nexalin's Breakthrough DIFS™ Neurostimulation Device Demonstrates Reduction in Blood Pressure while Enhancing Mental Health According to New Landmark Study. Low float. COH $3.4M good for 10.7 months
$Safety Shot (SHOT.US)$ PR 2/3 announced the termination of its at-the-market (ATM) equity offering program, citing strong financial position and positive outlook.
$Safe Pro Group (SPAI.US)$ PR 1/30 Enters Multi-Year Agreement for its Patented Drone AI Demining Platform with Ukraine's Leading Grain Export and Agricultural Organization. COH $900K good for 2.8 months
$Unusual Machines (UMAC.US)$ PR 2/3 Enters Into a Definive Agreement to Acquire Drone Software Company Aloft Technologies to Grow the American Drone Ecosystem. Low float. COH $3M good for 9.9 months
$Valneva (VALN.US)$ PR 1/30 Announces New IXIARO® Supply Contract with the U.S. Government Worth a Minimum of $32.8 Million - Department of Defense (DoD) for the supply of its Japanese encephalitis (JE) vaccine, IXIARO®. No dilution risk.
$Vanda Pharmaceuticals (VNDA.US)$ PR 2/3 Vanda Pharmaceuticals and Anaptys Announce Exclusive Global License Agreement for Vanda to Develop and Commercialize Imsidolimab for Generalized Pustular Psoriasis. COH $369.7M
$Wearable Devices (WLDS.US)$ PR 2/3 announced the development of Large MUAP Models (LMM), a groundbreaking advancement in AI-powered neural gesture control technology. COH $6.4M good for 10 months
▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️
POSSIBLE MOMENTUM PLAYS
$Digital Turbine (APPS.US)$
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If you don’t appreciate my watchlist, STAY AWAY and I won’t think twice blocking you. I shun uncouth and toxic people in my life.
AGAIN, NEVER OPEN A POSITION WITHOUT ANALYZING CHART, INDICATORS, ORDER BOOK, SHORTS AVAILABILITY
To my silent stalkers: You are welcome 🤣
▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️
NEWS FEBRUARY 6 (Thursday)
$Aurora Cannabis (ACB.US)$ $SNDL Inc (SNDL.US)$ PR after market closed 2/6 Announces Supply Agreement. SNDL is expected to supply Aurora with premium cannabis flower product. The term of the agreement is for three years with an option to extend and an estimated value of $27 million.
$Alumis (ALMS.US)$ $Acelyrin (SLRN.US)$ SPR 2/6 Alumis and ACELYRIN to Merge Creating a Late-Stage Clinical Biopharma Company Dedicated to Innovating, Developing and Commercializing Transformative Therapies for Immune-mediated Diseases. Pro forma cash position of approximately $737 million as of December 31, 2024, provides runway into 2027. Alumis and ACELYRIN stockholders to own ~55% and ~45%, respectively. This involves dilution as new shares Will be issued to facilitate merger. This may go up if market sentiment perceives the merger outweighs dilution.
$Clear Channel Outdoor (CCO.US)$ PR 2/5 Sells Businesses in Mexico, Peru and Chile to Global Media US LLC! Receives $20 Million Cash at Closing Based on $34 Million Enterprise Value. No dilution risk
$Coya Therapeutics (COYA.US)$ PR 2/6 Reports Statistically Significant Improvement of Inflammatory Blood Markers in Patients with Alzheimer's Disease Following Monthly Dosing with Low-Dose IL-2, Further Supporting Clinical Development. Low float. COH $37.3M good for 42.5 months
$Dare Bioscience (DARE.US)$ PR 2/6 Announces Funding Award Notice from the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Support DARE-HPV Development Up to $2 million in grant funding. Low float. COH $60K. High risk for dilution
$Farmer Bros (FARM.US)$ PR AH 2/6 ER Second quarter fiscal 2025 net sales of $90 millio, Gross margin increased 43.1% YoY. Net income of $210,000 and improved adjusted EBITDA1 of $5.9 million. COH $2.5M
$Fusion Fuel Green (HTOO.US)$ PR AH 2/6 Complied with listing requirements. Low float.
$Jeffs' Brands (JFBR.US)$ PR 2/6 Enters Into Definitive Agreement to Complete Fort Products’ Merger with a Publicly Traded Company, at a Valuation of up to approximately $12 Million. The merger values Fort Products at approximately US $11.9 million, with Impact's valuation at US $3.3 million. Low float. SI 21.87%. COH $1M good for 1.8 months
$Mangoceuticals (MGRX.US)$ PR 2/5 Advances H1N1 Efficacy Study Noting Significant Reduction in Viral Load in Phase 1 Studies and Engages Vipragen Biosciences to Structure H5N1 Cohort for Expanded Research. Low float. No cash on hand
$Maris-Tech (MTEK.US)$ PR 2/6 secured its first Eastern European defense order through its UK-based distributor for multiple Jupiter Nano systems. The units will be integrated into weapon systems for a defense project in Eastern Europe, marking the company's expansion into a new defense market. 2/5 13G/A filed 8.1% up from 6.23%.
$New Century Logistics (NCEW.US)$ PR 2/6 2 13Gs 39% and 16%. This ran but it was news AH so it may get attention tomorrow too. Low float. 0 shares LTB. COH $360K
$Algorhythm (RIME.US)$ PR 2/5 Company Clears All Outstanding Cashless Warrants from December Capital Raise. ALSO, this is going on RS Feb 10 so may have probable pre RS spike
$Satellogic (SATL.US)$ S PR 2/6 Satellogic and Telespazio Brasil Announce Multi-Year Contract for Low-Latency Satellite Imagery for the Brazilian Air Force. COH $6.5M good for 1.5 months
$SuperCom (SPCB.US)$ PR 2/6 SuperCom Secures over 200% growth in PureTrack GPS Monitoring units in Large Nationwide European EM Project and is expected to surpass 400% growth by end of 2025. Low float. Remember this has a 13G filed 1/31. SI 12.63%. COH $1M
$Trinity Biotech (TRIB.US)$ PR 2/6 The latest analysis shows Trinity Biotech’s redesigned CGM sensor improves first-day accuracy, with a ~35% better Mean Absolute Relative Difference (MARD) and over 50% better Mean Absolute Difference (MAD) than the previous Waveform product. First-day accuracy has been a challenge industry-wide due to the body’s response to sensor insertion. Relatively low float. COH $10.9M good for 29.8 months
$Urban-gro (UGRO.US)$ PR 2/6 secured a significant $24 million construction contract with a leading Midwest-based Multi-State Operator (MSO) for building a state-of-the-art vertically integrated cannabis facility.
▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️
PREVIOUS DAYS’ NEWS FOR POSSIBLE DELAYED MARKET REACTION (I advise you to save these news because I won’t repost the details and will just be ticker symbols.
$Cognition Therapeutics (CGTX.US)$ PR 1/30 Positive Phase 2 Study of Zervimesine in Dementia with Lewy Bodies (DLB).
$Datasea (DTSS.US)$ PR 2/5 Pre-Announces Second Quarter Revenue of $20.5 Million, up 81% Year-over-Year; Gross profit increase of 310% YoY. China low float stock.
$EyePoint Pharmaceuticals (EYPT.US)$ PR 2/5 Announces Positive Six-Month Results for the Phase 2 VERONA Clinical Trial of DURAVYU™ for Diabetic Macular Edema Meeting Primary and Secondary Endpoints. Beaten by shorts today. SI 21.78%. COH $348M.
$Helix Energy Solutions (HLX.US)$ PR AH 2/5 Awarded Significant Trenching Services Contract, one of the largest trenching awards of the company. Helix is a global leader in subsea robotics and trenching. No dilution risk
$Inspira Technologies Oxy (IINN.US)$ PR 2/5 announced the integration of a next-generation oxygenation indicator into its AI-powered HYLA blood sensor technology. This enhancement enables continuous monitoring of tissue oxygenation and early hypoxia detection without requiring intermittent blood draws. Low float. SI 16.54%. COH $4.5M good for 5.6 months
$Knightscope (KSCP.US)$ Achieves Full Federal Risk and Authorization Management Program (FedRAMP®) Authorization, Unlocking Federal Growth.
$Comstock Inc (LODE.US)$ PR 2/4 Approved for $152 Million Allocation for Oklahoma Qualified
$Lucky Strike Entertainment (LUCK.US)$ PR 2/5 ER Net income improved significantly to $28.3M from prior year loss of $63.5M. Maintained positive guidance for FY2025 with expected revenue of $1.23-1.28B. Low float. SI 56.61%. 0 shares LTB.
$MAIA Biotechnology (MAIA.US)$ PR 2/4 Announces Positive Efficacy Updates for Phase 2 THIO-101 Trial in Advanced Non-Small Cell Lung Cancer. Showed median overall survival of 16.9 months compared to 56 months in similar setting.
$Nexalin Technology (NXL.US)$ PR 2/3 Nexalin's Breakthrough DIFS™ Neurostimulation Device Demonstrates Reduction in Blood Pressure while Enhancing Mental Health According to New Landmark Study. Low float. COH $3.4M good for 10.7 months
$Safety Shot (SHOT.US)$ PR 2/3 announced the termination of its at-the-market (ATM) equity offering program, citing strong financial position and positive outlook.
$Safe Pro Group (SPAI.US)$ PR 1/30 Enters Multi-Year Agreement for its Patented Drone AI Demining Platform with Ukraine's Leading Grain Export and Agricultural Organization. COH $900K good for 2.8 months
$Unusual Machines (UMAC.US)$ PR 2/3 Enters Into a Definive Agreement to Acquire Drone Software Company Aloft Technologies to Grow the American Drone Ecosystem. Low float. COH $3M good for 9.9 months
$Valneva (VALN.US)$ PR 1/30 Announces New IXIARO® Supply Contract with the U.S. Government Worth a Minimum of $32.8 Million - Department of Defense (DoD) for the supply of its Japanese encephalitis (JE) vaccine, IXIARO®. No dilution risk.
$Vanda Pharmaceuticals (VNDA.US)$ PR 2/3 Vanda Pharmaceuticals and Anaptys Announce Exclusive Global License Agreement for Vanda to Develop and Commercialize Imsidolimab for Generalized Pustular Psoriasis. COH $369.7M
$Wearable Devices (WLDS.US)$ PR 2/3 announced the development of Large MUAP Models (LMM), a groundbreaking advancement in AI-powered neural gesture control technology. COH $6.4M good for 10 months
▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️
POSSIBLE MOMENTUM PLAYS
$Digital Turbine (APPS.US)$
$Safe & Green (SGBX.US)$
$T2 Biosystems (TTOO.US)$
$Meiwu Technology (WNW.US)$
▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️
FORM 4s, 13Gs, 13Ds
$Ardelyx (ARDX.US)$ 1/22 Form 4 insider buy
$Assembly Biosciences (ASMB.US)$ 12/31 Form 4 insider buying. Low float
$Atara Biotherapeutics (ATRA.US)$ 2/6 13G 9.5%
$Bitcoin Depot (BTM.US)$ 2/6 13G 5.69%. Low float.
$Chijet Motor (CJET.US)$ 1/21 13G 8.72%.
$PMGC Holdings (ELAB.US)$ 1/31 13G 9.6%. Low float.
$Icon Energy (ICON.US)$ PR 1/30 3 13Gs 2 6.9%; (2)Jan 27 9.99%. Low float.
$KALA BIO (KALA.US)$ 12/31 Form 4 huge insider buying. Low float.
$NAYA Biosciences (NAYA.US)$ 1/16 16 13Gs 9.99% and 6.9%. Low float.
$Outlook Therapeutics (OTLK.US)$ 1/22 13D/A 38.6% ownership up from 25%
$SuperCom (SPCB.US)$ 1/31 13G 7.8%. Low float.
$SaverOne 2014 (SVRE.US)$ 2/5 13G 4.99%.
$TriSalus Life Sciences (TLSI.US)$ 2/6 Multiple Form 4s insider buying. Low float.
$T2 Biosystems (TTOO.US)$
$Meiwu Technology (WNW.US)$
▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️
FORM 4s, 13Gs, 13Ds
$Ardelyx (ARDX.US)$ 1/22 Form 4 insider buy
$Assembly Biosciences (ASMB.US)$ 12/31 Form 4 insider buying. Low float
$Atara Biotherapeutics (ATRA.US)$ 2/6 13G 9.5%
$Bitcoin Depot (BTM.US)$ 2/6 13G 5.69%. Low float.
$Chijet Motor (CJET.US)$ 1/21 13G 8.72%.
$PMGC Holdings (ELAB.US)$ 1/31 13G 9.6%. Low float.
$Icon Energy (ICON.US)$ PR 1/30 3 13Gs 2 6.9%; (2)Jan 27 9.99%. Low float.
$KALA BIO (KALA.US)$ 12/31 Form 4 huge insider buying. Low float.
$NAYA Biosciences (NAYA.US)$ 1/16 16 13Gs 9.99% and 6.9%. Low float.
$Outlook Therapeutics (OTLK.US)$ 1/22 13D/A 38.6% ownership up from 25%
$SuperCom (SPCB.US)$ 1/31 13G 7.8%. Low float.
$SaverOne 2014 (SVRE.US)$ 2/5 13G 4.99%.
$TriSalus Life Sciences (TLSI.US)$ 2/6 Multiple Form 4s insider buying. Low float.
▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️
POST RS FOR POSSIBLE SPIKE
▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️
STOCK EDUCATION
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
HannChau : I will not be silent stalker but always will be voice out 'stalker'![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
Best Yavo : can I ask what time frames do u look at when trading?
Jaguar8 OP Best Yavo : 1,3,5,15 for active trades
Best Yavo : thank you
MilaDing Best Yavo : When do you usually release Watchlist information?
72298961 : forever dropping
Jaguar8 OP 72298961 : Dont expect all stocks to rise.
103736983 : Thank you, Dr Jag